[Retracted] ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

Table 2

Correlation between ZFP36 mRNA expression and clinical characteristics of PCa patients.

Clinical characteristics	ZFP36 expression in TCGA dataset			ZFP36 expression in Taylor dataset
	Cases		value	Cases		value
ZFP36 expression
Benign	52		0.012	29		0.024
Cancer	498			150
Age (years)
<60	201		0.839	93		0.157
≥60	296			57
Serum PSA (ng/mL)
<4	—	—	—	24
≥4	—	—		123
Gleason scores
<8	292		0.002	117		<0.001
≥8	206			22
Clinical stage
<T2A	177		0.073	80		0.261
≥T2A	229			65
Pathological stage
<T3A	186		0.002	86		0.016
≥T3A	304			55
Metastasis
No	416		0.143	122		<0.001
Yes	82			28
Overall survival
Alive	487		0.599	131		<0.001
Die	10			19
PSA failure
Negative	439		0.003	104		<0.001
Positive	59			36
Surgical margin status
Negative	314		0.727	—	—	—
Positive	153			—	—